reference/14216401

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/14216401

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, N.I.H., Extramural
endingPage	613
issn	1533-4406 0028-4793
issueIdentifier	7
pageRange	603-613
publicationName	The New England journal of medicine
startingPage	603
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_448c3d7a8b95445db230c0de0b6d375a http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1bf8ae30ecb7ab0eb987f5517e8f762b http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f3aa70139f931b933bd7fe02023282e6 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_6a06f795e2776f8b4caa4cc13fa47f47 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_5a0eb2fadabf1dffb4d70280b760adba http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_75b4aef89f91e5f215302d04eecfe76d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8ec6bb6a92ceafb94b9714b835fd2e2f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_199db1bef4b0308c0639203aa0befa4f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e8f615bf5b287fda7b30414b3edb5860
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_933490e0ac970b006deeb03812e3a265 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_540574af8793e1fd484c8b14f35a9a3e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_69731bb36a4061fbaf74a48f03dfbd8c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a0bab4bd6ddfbb24b8a0838431a3ef2d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_baa0187f603b35cc21d42bb7fbd0fb60 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e74bdd3456a150b88bf80f5653515420 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_f33663b6a385f5a69e648e5c30cccb08 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3dc7a3ac42c1dd25a63453e8f5fe4792 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0f56a98e4c2ffe447f424e36950710b9 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8d87faf2b3ce78c62d4094373fc9a3ee http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_223846c010096590d34a0f29301fe1d1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4dd71feebfbd61575e58c2ffef165ed4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2513de0263dd68efc5840089ee734f14 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_140d531fe45484d8a77a2a7c03509aa8 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_5d6c1dff0ae57edce5cbc0eb3aaa9c72 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bb628e099c159159593e6eac3da6402b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_edf57934dd46ecd4282df6acfa28a89c http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e42ff9662f06e9f219ddec82b4a91f1f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e8f86ef234b63c9b2bd11545af8fee25 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_123935ddddab1766a5c91aaf15c3fc63 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1decc09a65e71066064d43d3e87fdd6e http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_769ee9a8cc118da772c7fe69db812cce http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_6abd2080e71579fcbe0d90996e896def http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b8e05198a267c04765e77296bf08a5c1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_9a06683ac22e40314f108d1ef303d692 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_0978e16672ff888762ee21e956865171 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_482a4b962ade8bb80437182bd6b10602 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ffa962c914cd0420f4c72586f4639747 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_63484cd8d267394e061b14d0d766f1ed http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_53fbe449997474420f0e117d9cc2d94f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_613c1b6a6a676799226ff2365d98d611 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_58a3303651172baed9d3bb1749a240ff http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ed2fba8e9291f232911e65ecbb35dcde http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_3aafd60315b8c5f72f3b24dd8c3d4357 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_7a486ab740ada09bc237ef618d21789b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_352b0d2a7271b534d65503c6f99806d1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_2dfce30e3eb20e0d588fda223800cd51 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b1ec79ed74cc62e3f65b2c70ab60131b http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ab4c91f3cbc8c2a7ef661b181091c50a http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_e98315a752a23b5d035124c56191b282 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_bc79a95891b0a177fe3cebdb647362ad http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_a6397a5fa2b6deab7471fcf84595f54f http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ea8675b69851a9c988522ec4c69cf4a0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_dded205a2d7952e8ba9c537ec5f0a257 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c01e9bce139e9bba90bbf0bc4c5f5f6d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_8153fe841d61d4fb2b9e55d3310da4e4 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_341a68e7593ef12524f440e3126d2b39 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_1681c1a4d9784020a14f076514ad2baa http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_14e5f8cf8973ebde182d969e82720dc0 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b863f0c31018b938b0886a8e73a5e602
bibliographicCitation	Herold KC, Bundy BN, Long SA, Bluestone JA, DiMeglio LA, Dufort MJ, Gitelman SE, Gottlieb PA, Krischer JP, Linsley PS, Marks JB, Moore W, Moran A, Rodriguez H, Russell WE, Schatz D, Skyler JS, Tsalikian E, Wherrett DK, Ziegler AG, Greenbaum CJ; Type 1 Diabetes TrialNet Study Group. An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. N Engl J Med. 2019 Aug 15;381(7):603–13. PMID: 31180194; PMCID: PMC6776880.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d89177935befec6fbf22024f8e24bc38 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_885310bb4afe7bef2aa6ff7c8ac6a6ed http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c3a87ebe7dd7b16e1990961eaf87cb3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2587f3f2be07e8d878652c74184e4df http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23215504c616f094c0e036c5be2fb31a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b2d5b8b203a40a75128781cc9d982e6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a11e2d5d5633125120cd13aded38d5ab http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_66d6d60ea7fc070d9689d08f201fde46 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d093dd44caa0b06d04221e39ca40c14e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_39f4a32b6c390631a2b8cb43566faa8a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_abfd91e6d9d43c96314043903df11655 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5e9c36a2882eba49bfc27eb5016404d1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5be8a6963af03b35991a6971a814cdd3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b0612d8f2757809a7b4748459c216fe http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ed87f8f6f374fdce9f2c9a4d3cef6b50 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_84286c8bedddaae76940cec64b344184 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3429-2796 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b50c247aea33f1a17a6256d45b2332c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_365eae002c24d2f73c94409133bb0772 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_582d488dfeb5c45d21b65ca6b26befdd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4d004ef80b4fc5cea3a1bace21cf10a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ef6a6e3a63bd8900172e53c34e2270d1
date	2019-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC6776880 https://doi.org/10.1056/nejmoa1902226 https://pubmed.ncbi.nlm.nih.gov/31180194
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5985 https://portal.issn.org/resource/ISSN/1533-4406 https://portal.issn.org/resource/ISSN/0028-4793
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
discusses	http://id.nlm.nih.gov/mesh/M0024205 http://id.nlm.nih.gov/mesh/M0024204 http://id.nlm.nih.gov/mesh/M0539176 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0026174
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_244409db6bf0f9797b822bc48b8463b1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3ad2119464233024868ba3753ac34390 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7660 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8392 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7442 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7001 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10098 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_a42157ebb7bc4228733145cab4dfadd8 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_342f8338fd42f5f0923df8c6b8643de1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_93e2ea5cd2a12ba342a74027af07f411 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_118dd6abf266102dccb53d8fc658affb http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4a78945dc744712442eb264a13733720 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cdf1e220d89c2dcd2e000c3d105bf93e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_c1da861a271010c66f326fc0e7473dbb http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d289b014f359524dc834745069e482ec http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e3f40766f2a0c0395a5a98440cd6150d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_55172d42d1f1e96d17c012d965853100

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID473153840

Total number of triples: 128.